Lin, Hui-Zhen
Liang, Zhi-Kun
Huang, Jun-Ju
Yang, Yong
Huang, Yan
Wu, Zhi-Shen
Tan, Jin-Lin
Huang, Sheng
Ruan, Shi-Han
Xu, Bing-Yi
Ruan, Ze-Fan
Huang, Tao-Sheng
Wang, Qi-Guang
Xie, Long https://orcid.org/0000-0002-2138-888X
Funding for this research was provided by:
Putian Science and Technology Bureau (2023SY004)
Article History
Received: 19 June 2025
Accepted: 23 January 2026
First Online: 5 February 2026
Declarations
:
: All authors declare no competing interests as defined by the publisher, or other interests that might be perceived to influence the results and/or discussion reported in this paper.
: This study was conducted in accordance with the ethical principles outlined in the latest amendments of the 1964 Declaration of Helsinki and Good Clinical Practice. The research protocol was reviewed and approved by the Research Ethics Committee of the First Hospital of Putian (approval number 2022027) in Putian, and the Medicine and Biological Engineering Technology Research Centre of the Ministry of Health (MBETRC) in Guangzhou, China. Written informed consent was obtained from all patients prior to their enrollment in the study. In alignment with ethical mandates, data related to disease diagnosis were meticulously collected and anonymized before analysis. Additionally, all experimental procedures employed in this study were strictly in compliance with relevant national technical specifications, ensuring the highest standards of biosafety and ethical conduct.